title: Authors' response to the letter by Dr. Eisa-Beygi.
authors.affiliation: Department of Neurology, University Medical Center Freiburg, Germany; Department of Neurology and Clinical Neurophysiology, Medical Center Esslingen, Academic Teaching Hospital of the University of Tübingen, Germany. Electronic address: m.reinhard@klinikum-esslingen.de.
authors.forename: Matthias
authors.initials: M
authors.lastname: Reinhard
authors.affiliation: Department of Neurology, University Medical Center Freiburg, Germany.
authors.forename: Florian
authors.initials: F
authors.lastname: Schuchardt
authors.affiliation: Department of Neuroradiology, University Medical Center Freiburg, Germany.
authors.forename: Stephan
authors.initials: S
authors.lastname: Meckel
authors.affiliation: Department of Internal Medicine, University Medical Center Freiburg, Germany.
authors.forename: Jürgen
authors.initials: J
authors.lastname: Heinz
authors.affiliation: Department of Human Genetics, University Medicine Greifswald and Interfaculty Institute of Genetics and Functional Genomics, University of Greifswald, Germany.
authors.forename: Ute
authors.initials: U
authors.lastname: Felbor
authors.affiliation: Department of Neurosurgery, University Medical Center Essen, Germany.
authors.forename: Ulrich
authors.initials: U
authors.lastname: Sure
authors.affiliation: Institute for Clinical Chemistry and Laboratory Medicine, University Medical Center Freiburg, Germany.
authors.forename: Ulrich
authors.initials: U
authors.lastname: Geisen
mesh_terms: D020786:Hemangioma, Cavernous, Central Nervous System / Q000517:prevention & control*; D006470:Hemorrhage / Q000188:drug therapy; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D019821:Simvastatin / Q000627:therapeutic use*
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D019821:Simvastatin